NanoBio Obtains $11,000,000 Series C Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3c9d269-9940-4f70-b860-092334c9c7ce&Preview=1
Date
11/29/2012
Company Name
NanoBio
Mailing Address
2311 Green Road Ann Arbor, MI 48105
Company Description
NanoBio Corporation is a biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat technology platform.
Website
http://www.nanobio.com
Transaction Type
Venture Equity
Transaction Amount
$11,000,000
Transaction Round
Series C
Proceeds Purposes
Proceeds from the financing will be used to advance the company’s development programs for herpes labialis (cold sores), cystic fibrosis and nanoemulsion-based vaccines for respiratory syncytial virus (RSV) and genital herpes (HSV2).
M&A Terms
Venture Investor
Venture Investors
Venture Investor
Merck Capital Ventures
Venture Investor
Perseus